Healthcarehttps://www.bakermckenzie.com/en/rss-landing/industries/healthcareHealthcareen{9F91AB61-D189-4278-856B-4E2849D16124}https://www.bakermckenzie.com/en/newsroom/2024/03/leif-king-and-randy-sunberg-recognized-among-legal-500Mergers & AcquisitionsHealthcare & Life SciencesTechnology, Media & Telecommunications Baker McKenzie Partners Leif King and Randy Sunberg Recognized Among Legal 500's 2024 M&A PowerlistTue, 12 Mar 2024 00:00:00 Z{961A8786-6EAF-459F-9C92-D10EFE44135A}https://www.bakermckenzie.com/en/insight/publications/guides/ukrainian-laws-in-wartimeKyivHealthcare & Life SciencesBanking & FinanceEmployment & CompensationTaxReal EstateIntellectual PropertyAntitrust & CompetitionFinancial InstitutionsUkrainian Laws in WartimeTue, 05 Mar 2024 00:00:00 Z{5C85CE49-238A-49DA-A4E5-5BFC00DCE866}https://www.bakermckenzie.com/en/newsroom/2024/02/takeda-enters-agreement-with-protagonistHealthcare & Life SciencesLife Sciences TransactionsPharmaceuticals & BiotechTransactionsBaker McKenzie Client Takeda Enters Worldwide License and Collaboration Agreement for RusfertideFri, 02 Feb 2024 00:00:00 Z{65CF6511-6C90-4F64-8C7E-5DED00EC29CF}https://www.bakermckenzie.com/en/insight/publications/2024/01/who-releases-ai-ethics-and-governance-guidanceSingaporeHealthcare & Life SciencesTechnology, Media & Telecommunications WHO Releases AI Ethics and Governance Guidance for Large Multimodal ModelsWed, 31 Jan 2024 00:00:00 Z{7155E231-D2EF-4D7F-AAC0-999BFFFFF14D}https://www.bakermckenzie.com/en/insight/events/2022/01/global-healthcare-life-sciences-webinar-seriesSingaporeHealthcare & Life SciencesIntellectual PropertySupply ChainsInternational Commercial & TradeDigital TransformationMedical DevicesPharmaceuticals & BiotechHealthcare & Life Sciences RegulatoryDigital HealthGlobal Healthcare & Life Sciences Webinar SeriesMon, 29 Jan 2024 09:32:45 Z{345A0C75-62FF-4AF9-B7A0-AE5991D26D1F}https://www.bakermckenzie.com/en/insight/events/2021/06/asia-pacific-competition-spotlightSingaporeManilaKuala LumpurTokyoJakartaBeijingHong KongShanghaiBrisbaneMelbourneSydneyTaipeiBangkokHanoiHo Chi Minh CityAntitrust & CompetitionConsumer Goods & RetailHealthcare & Life SciencesTechnology, Media & Telecommunications Digital HealthAsia Pacific Competition SpotlightFri, 26 Jan 2024 03:36:42 Z{06A43442-BF99-48B1-A074-FBDE5F5FCA83}https://www.bakermckenzie.com/en/insight/publications/2024/01/year-ahead-global-disputes-forecast-2024Dispute ResolutionInvestigations, Compliance & EthicsEnergy, Mining & InfrastructureConsumer Goods & RetailFinancial InstitutionsHealthcare & Life SciencesIndustrials, Manufacturing & TransportationTechnology, Media & Telecommunications International ArbitrationThe Year Ahead: Global Disputes Forecast 2024 ReportWed, 24 Jan 2024 00:00:00 Z{C86986E8-0680-476C-B473-8CDA9AFEE10A}https://www.bakermckenzie.com/en/insight/publications/2024/01/seize-korea-opportunitiesSeoulDigital TransformationTransactionsEnergy TransitionEnergy, Mining & InfrastructureIndustrials, Manufacturing & TransportationFinancial InstitutionsHealthcare & Life SciencesTechnology, Media & Telecommunications Banking & FinanceMergers & AcquisitionsDispute ResolutionData & TechnologyInvestigations, Compliance & EthicsProjectsSupporting clients to seize Korea’s substantial opportunitiesMon, 15 Jan 2024 00:00:00 Z{873F3A60-287B-4673-800A-E652A8B20B4B}https://www.bakermckenzie.com/en/insight/publications/guides/guide-to-ipos-for-biotech-and-pharma-companiesCapital MarketsHealthcare & Life SciencesPharmaceuticals & BiotechLife Sciences TransactionsDigital HealthGuide to IPOs for Biotech and Pharma CompaniesThu, 21 Dec 2023 00:00:00 Z{B1BE8511-B8C2-46D9-B4D3-4DE91E90E278}https://www.bakermckenzie.com/en/newsroom/2023/12/chambers-asia-pacific-2024-ranks-baker-mckenzie-in-151-practicesBanking & FinanceData & TechnologyIntellectual PropertyInvestment FundsIslamic FinanceHealthcare & Life SciencesTechnology, Media & Telecommunications Chambers Asia Pacific 2024 ranks Baker McKenzie in 151 practicesWed, 20 Dec 2023 00:00:00 Z{E841F88F-B66F-4DBA-9C5C-D98863BB7433}https://www.bakermckenzie.com/en/newsroom/2023/12/mrna-victoria-new-facilityMelbourneHealthcare & Life SciencesBaker McKenzie assists Government of Victoria to deliver a new state-of-the-art manufacturing facility for mRNA therapies at La Trobe UniversityWed, 13 Dec 2023 00:00:00 Z{7BBBC509-A5A2-46F8-962F-66F176F58242}https://www.bakermckenzie.com/en/insight/publications/2023/12/2023-life-sciences-asia-pacificMergers & AcquisitionsHealthcare & Life SciencesArtificial IntelligenceHow Has 2023 Panned Out for the Life Sciences Industry in Asia Pacific?Thu, 07 Dec 2023 00:00:00 Z{E063561E-6536-4445-9361-DC10F68EB065}https://www.bakermckenzie.com/en/insight/publications/resources/talking-m-and-aMergers & AcquisitionsPrivate EquityMultinational Divestitures/Carve-outsHealthcare & Life SciencesTransactionsTalking M&ATue, 21 Nov 2023 00:00:00 Z{8459561B-6B93-4544-9485-DCEEF73B2D5C}https://www.bakermckenzie.com/en/newsroom/2023/11/spimaco-acquisition-of-osmopharm-sharesMergers & AcquisitionsAntitrust & CompetitionHealthcare & Life SciencesBaker McKenzie advises SPIMACO in acquisition of 68.0% of shares of OsmopharmTue, 21 Nov 2023 00:00:00 Z{21C801F9-723C-452E-80F2-CD55EE79CEB4}https://www.bakermckenzie.com/en/newsroom/2023/11/baker-mckenzie-announces-global-revenuesEmployment & CompensationAntitrust & CompetitionHealthcare & Life SciencesProjectsEnergy, Mining & InfrastructureBaker McKenzie Announces Global Revenues of USD $3.3 BillionWed, 01 Nov 2023 00:00:00 Z{1994793A-011D-447A-828E-43D6ADAF44BA}https://www.bakermckenzie.com/en/newsroom/2023/10/sanofi-completes-sale-of-latam-generics-businessMergers & AcquisitionsHealthcare & Life SciencesTransactionsBaker McKenzie Client Sanofi Completes Sale of Latin America Generics Business - Genfar Tue, 24 Oct 2023 00:00:00 Z{01F5A71A-81BA-4A84-BC2F-E3F99D704209}https://www.bakermckenzie.com/en/insight/publications/resources/health-podHealthcare & Life SciencesPharmaceuticals & BiotechMedical DevicesFDAHealthcare & Life Sciences RegulatoryLife Sciences TransactionsDigital HealthProjectsEnergy, Mining & InfrastructureRenewable Energy & Clean TechnologyEnergy TransitionThe Health PodWed, 19 Jul 2023 00:00:00 Z{9DE84DE1-AF09-4FB9-992B-1AAE86C92F67}https://www.bakermckenzie.com/en/newsroom/2023/06/baker-mckenzie-advises-prenetics-on-jv-with-professor-dennis-loHong KongSydneyBangkokNew YorkMergers & AcquisitionsIntellectual PropertyHealthcare & Life SciencesCapital MarketsBaker McKenzie advises Prenetics on USD 200 million joint venture with globally renowned scientist Professor Dennis LoWed, 28 Jun 2023 00:00:00 Z{58A29B42-D8AC-4024-AE9F-ACEB9870D64A}https://www.bakermckenzie.com/en/newsroom/2023/06/chambers-usa-2023-rankingsChicagoDallasHoustonLos AngelesMiamiNew YorkPalo AltoSan FranciscoWashington, DCInternational ArbitrationEmployment & CompensationTaxInternational Commercial & TradeHealthcare & Life SciencesBanking & FinanceMergers & AcquisitionsIntellectual PropertyDispute ResolutionFranchise, Distribution & Global Brand ExpansionBaker McKenzie Earns 42 Practice Group and 81 Individual Rankings in Chambers USA 2023 GuideTue, 06 Jun 2023 00:00:00 Z{9D36450E-05F0-4282-B5A8-27971F8F84E1}https://www.bakermckenzie.com/en/newsroom/2023/05/new-global-practice-group-and-industry-group-leadersIntellectual PropertyTaxFinancial InstitutionsTechnology, Media & Telecommunications Capital MarketsPrivate EquityHealthcare & Life SciencesAntitrust & CompetitionBanking & FinanceEmployment & Compensation Baker McKenzie announces new Global Practice Group and Industry Group leadersWed, 10 May 2023 00:00:00 Z{009AB7D2-8F83-4256-8BA6-3ACAB8C3F1DC}https://www.bakermckenzie.com/en/newsroom/2023/new-chambers-life-sciences-practice-guide-2023Healthcare & Life SciencesNew Chambers Life Sciences Practice Guide 2023Thu, 27 Apr 2023 00:00:00 Z{3A7CB3C3-18DF-4B6B-B73B-9085DFEDAF60}https://www.bakermckenzie.com/en/newsroom/2023/04/new-mountain-capital-acquires-perkinelmerMergers & AcquisitionsHealthcare & Life SciencesEmployment & CompensationBaker McKenzie advises New Mountain Capital on its acquisition of PerkinElmer, Inc's Applied, Food and Enterprise Services businessesWed, 12 Apr 2023 00:00:00 Z{C2EB5DFB-1580-431E-B2C9-ADD642377DA6}https://www.bakermckenzie.com/en/insight/publications/guides/doing-business-peruLimaConsumer Goods & RetailEnergy, Mining & InfrastructureFinancial InstitutionsHealthcare & Life SciencesIndustrials, Manufacturing & TransportationHotels, Resorts & TourismTechnology, Media & Telecommunications Private EquityDispute ResolutionData & TechnologyInvestigations, Compliance & EthicsCapital MarketsBanking & FinanceAntitrust & CompetitionEmployment & CompensationInternational Commercial & TradeMergers & AcquisitionsPrivate EquityProjectsRestructuring & InsolvencyTaxDoing Business in Peru 2023Wed, 29 Mar 2023 00:00:00 Z{724A1196-F118-4159-9098-FDAB2FC3F954}https://www.bakermckenzie.com/en/insight/publications/guides/doing-business-in-the-united-arab-emirates-2023Abu DhabiDubaiAntitrust & CompetitionBanking & FinanceData & TechnologyDispute ResolutionEmployment & CompensationMergers & AcquisitionsIntellectual PropertyInternational Commercial & TradeFinancial InstitutionsTechnology, Media & Telecommunications Healthcare & Life SciencesInternational ArbitrationFinancial Services RegulatoryVAT / Indirect TaxTaxDoing Business in the United Arab Emirates 2023Tue, 21 Mar 2023 00:00:00 Z{09926F50-4070-4C1C-971A-B1BAC92EBC8B}https://www.bakermckenzie.com/en/newsroom/2023/02/chambers-global-2023-ranks-baker-mckenzie-in-316Banking & FinanceCapital MarketsDispute ResolutionIntellectual PropertyMergers & AcquisitionsEmployment & CompensationInternational Commercial & TradeEnergy, Mining & InfrastructureProjectsHealthcare & Life SciencesPrivate EquityFranchise, Distribution & Global Brand ExpansionChambers Global 2023 Ranks Baker McKenzie in 316 PracticesFri, 24 Feb 2023 00:00:00 Z{FA37974C-0943-40C7-90E1-E3DA526B3D84}https://www.bakermckenzie.com/en/newsroom/2023/02/abbott-laboratoriesMergers & AcquisitionsEmployment & CompensationIntellectual PropertyReal EstateTaxBanking & FinanceDispute ResolutionTransactionsHealthcare & Life SciencesMedical DevicesLife Sciences TransactionsBaker McKenzie Advises Abbott Laboratories in $890 Million AcquisitionThu, 09 Feb 2023 00:00:00 Z{590C2E3B-0898-4975-936C-EB846D2D597D}https://www.bakermckenzie.com/en/newsroom/2023/02/zur-rose-groupCapital MarketsAntitrust & CompetitionHealthcare & Life SciencesBaker McKenzie acts as legal adviser for Zur Rose Group AG in sale of Swiss business to Migros GroupTue, 07 Feb 2023 00:00:00 Z{9857372B-B43C-4F60-9526-C3DA459B1CC2}https://www.bakermckenzie.com/en/newsroom/2023/01/xin-taoWashington, DCFDAHealthcare & Life SciencesHealthcare & Life Sciences RegulatoryBaker McKenzie Adds Leading FDA Regulatory Lawyer Xin Tao in Washington, DCMon, 09 Jan 2023 00:00:00 Z{9B2EA188-5F4F-4977-A1C9-0A6019D62298}https://www.bakermckenzie.com/en/insight/publications/2022/12/intended-extension-transitional-periodHealthcare & Life SciencesWaiting for your MDR Certificates? 5 takeaways on the intended extension to transitional periodsFri, 16 Dec 2022 00:00:00 Z{E272A02E-3A80-4CB9-B5C8-FF658D387E97}https://www.bakermckenzie.com/en/insight/publications/guides/global-public-ma-guide-fourth-editionBanking & FinanceCapital MarketsBanksDigital HealthConsumer Goods & RetailFinancial InstitutionsEnergy, Mining & InfrastructureHealthcare & Life SciencesIndustrials, Manufacturing & TransportationPrivate EquityMergers & AcquisitionsProjectsTechnology, Media & Telecommunications Global Public M&A Guide Wed, 30 Nov 2022 00:00:00 Z{17E7907C-1A18-4C3D-B2C6-ABE91BDC7D86}https://www.bakermckenzie.com/en/newsroom/2022/11/minoryxNew YorkChicagoBrusselsMadridHealthcare & Life SciencesIntellectual PropertyInternational Commercial & TradeBaker McKenzie Advises Minoryx in Strategic Alliance to Develop a New CNS Therapy in EuropeThu, 10 Nov 2022 00:00:00 Z{519E8791-D24E-401B-A041-2289A1DFD980}https://www.bakermckenzie.com/en/newsroom/2022/10/wilbur-ellisAntitrust & CompetitionTaxMergers & AcquisitionsTax for M&A and ReorganizationsEconomic ServicesLife Sciences TransactionsHealthcare & Life SciencesTransactionsIndustrials, Manufacturing & TransportationChemicals & PlasticsBaker McKenzie Advises Wilbur-Ellis in Merger to Form Leading Global Life Sciences and Specialty Chemicals Solutions Distribution Platform with Combined Sales of Approximately EUR 3 BillionFri, 14 Oct 2022 00:00:00 Z{20BF2C74-E54F-41A9-9C40-51D7B6A74F8E}https://www.bakermckenzie.com/en/insight/publications/2022/10/pharmaceutical-trademark-trendsIntellectual PropertyHealthcare & Life SciencesBrand ManagementPharmaceutical Trademark TrendsMon, 10 Oct 2022 00:00:00 Z{5A846A0A-AE86-481E-84A4-C6665766BFC6}https://www.bakermckenzie.com/en/insight/publications/guides/global-attorney-client-privilege-guideDispute ResolutionInvestigations, Compliance & EthicsConsumer Goods & RetailEnergy, Mining & InfrastructureFinancial InstitutionsHealthcare & Life SciencesIndustrials, Manufacturing & TransportationTechnology, Media & Telecommunications International ArbitrationGlobal Attorney-Client Privilege GuideWed, 21 Sep 2022 00:00:00 Z{DF6351CE-BE9D-4673-B7AC-7B3821DB52C6}https://www.bakermckenzie.com/en/newsroom/2022/09/uniphar-acquires-orspecMergers & AcquisitionsHealthcare & Life SciencesBaker McKenzie has successfully advised Uniphar plc on its acquisition of the Orspec Group Thu, 01 Sep 2022 00:00:00 Z{74DEC447-BDD8-41D9-9086-701ECB48DCC7}https://www.bakermckenzie.com/en/newsroom/2022/08/bm-advises-mrna-victoria-on-vaccinesHealthcare & Life SciencesBaker McKenzie advises mRNA Victoria on agreement to manufacture mRNA vaccines in Victoria Tue, 16 Aug 2022 00:00:00 Z{90E077C8-C456-4C14-969B-3020B4C16606}https://www.bakermckenzie.com/en/insight/publications/2022/07/european-health-data-spaceHealthcare & Life SciencesHealthcare & Life Sciences RegulatoryData PrivacyThe European Health Data Space - A Trojan Horse for Pharma and Medtech?Sun, 31 Jul 2022 00:00:00 Z{DA6EB10E-44A4-4D95-AA1F-FA8DE1348677}https://www.bakermckenzie.com/en/newsroom/2022/07/three-victories-for-baker-mckenzieHealthcare & Life SciencesThree victories for Baker McKenzie, with Goisis and Allena, in Rome, Palermo and Naples for Bio-Rad Laboratories in the immunohematology sectorMon, 25 Jul 2022 00:00:00 Z{F8F7DA0C-11A8-4E39-A0C3-E205584E8188}https://www.bakermckenzie.com/en/newsroom/2022/07/bm-expands-its-partnership-in-switzerlandBanking & FinanceIntellectual PropertyMergers & AcquisitionsHealthcare & Life SciencesPrivate EquityRestructuring & InsolvencyBaker McKenzie is expanding its partnership in Switzerland and worldwideFri, 01 Jul 2022 00:00:00 Z{BCF8305A-B295-4A5F-8153-5BAD03E1C7C1}https://www.bakermckenzie.com/en/newsroom/2022/06/galapagos-on-its-acquisition-of-cellpoint-and-aboundbioMergers & AcquisitionsHealthcare & Life SciencesTransactionsBaker McKenzie advises Galapagos on its acquisition of CellPoint and AboundBio Tue, 28 Jun 2022 00:00:00 Z{4F4CF9E3-EC18-4B4B-85A6-59CC22ABFEF6}https://www.bakermckenzie.com/en/insight/publications/resources/european-recovery-planAntitrust & CompetitionDigital TransformationEnergy TransitionHealthcare & Life SciencesEU Competition & Regulatory AffairsEuropean Recovery PlanFri, 24 Jun 2022 00:00:00 Z{68D38363-7549-4C35-A857-A8A97D98BBAE}https://www.bakermckenzie.com/en/newsroom/2022/06/chambers-usa-2022New YorkChicagoMiamiDallasHoustonPalo AltoLos AngelesTaxDispute ResolutionEmployment & CompensationInvestigations & White-Collar CrimeData PrivacyHealthcare & Life SciencesMergers & AcquisitionsEnvironment & Climate ChangeFranchise, Distribution & Global Brand ExpansionInternational Commercial & TradeBaker McKenzie Ranked in Chambers USA 2022, with 41 Practice Groups and 79 Lawyers RecognizedThu, 02 Jun 2022 00:00:00 Z{7C376431-E4AC-4477-9AF8-9BA400BB76BF}https://www.bakermckenzie.com/en/newsroom/2022/05/africa-risingJohannesburgCairoParisMergers & AcquisitionsTaxBanking & FinanceProjectsEnergy, Mining & InfrastructureHealthcare & Life SciencesAntitrust & CompetitionDispute ResolutionEmployment & CompensationAfrica Rising - quotes in celebration of Africa Day Wed, 25 May 2022 00:00:00 Z{45AE6526-5AD5-46D6-93F2-D2925B9443E2}https://www.bakermckenzie.com/en/newsroom/2022/05/bristol-myers-squibb-lotteMergers & AcquisitionsHealthcare & Life SciencesBaker McKenzie Advises Bristol Myers Squibb on Sale of Manufacturing Facility to LOTTETue, 17 May 2022 00:00:00 Z{728D0F94-0F0A-4FAB-AE91-E264A9F5A26B}https://www.bakermckenzie.com/en/newsroom/2022/05/bristol-myers-squibbNew YorkDallasWashington, DCLondonBrusselsIntellectual PropertyAntitrust & CompetitionHealthcare & Life SciencesLife Sciences TransactionsBaker McKenzie Advised Bristol Myers Squibb in Strategic Collaboration with Amphista TherapeuticsFri, 13 May 2022 00:00:00 Z{5724C10B-75A0-4996-B2EC-71E76EF33EFE}https://www.bakermckenzie.com/en/newsroom/2022/05/bm-thailand-doping-control-in-sport-actHealthcare & Life SciencesBaker McKenzie Thailand provided pro bono advice to sports and doping agencies to align Doping Control in Sport ActThu, 12 May 2022 00:00:00 Z{3419F540-2827-4D55-A0A8-C49A94AB48F9}https://www.bakermckenzie.com/en/insight/publications/resources/data-pulseIntellectual PropertyHealthcare & Life SciencesLife Sciences TransactionsPharmaceuticals & BiotechFDADigital HealthHealthcare & Life Sciences RegulatoryData & TechnologyDigital TransformationData PULSEThu, 05 May 2022 00:00:00 Z{5D184EC0-0D2B-4188-9763-FE8CCE4D3510}https://www.bakermckenzie.com/en/newsroom/2022/04/best-lawyer-australia-2023Mergers & AcquisitionsIntellectual PropertyEmployment & CompensationDispute ResolutionRestructuring & InsolvencyEnergy, Mining & InfrastructurePrivate EquityTechnology, Media & Telecommunications TaxHealthcare & Life SciencesAntitrust & CompetitionBest Lawyers recognizes Baker McKenzie lawyers in AustraliaThu, 28 Apr 2022 00:00:00 Z{E00583B2-DBDD-47D3-A373-06C16F9376F3}https://www.bakermckenzie.com/en/insight/publications/2022/04/chambers-life-sciences-guideDigital HealthFDAHealthcare & Life Sciences RegulatoryLife Sciences TransactionsMedical DevicesPharmaceuticals & BiotechHealthcare & Life SciencesSupply ChainsSustainability and ESGNew Chambers Life Sciences Practice Guide 2022Thu, 21 Apr 2022 00:00:00 Z{41A36A07-BC3B-4E1C-8692-51043F84C00F}https://www.bakermckenzie.com/en/insight/publications/2021/11/life-sciences-business-evolutionHealthcare & Life SciencesPharmaceuticals & BiotechMedical DevicesInvestigations, Compliance & EthicsData & TechnologyDigital TransformationLife Sciences TransactionsIntellectual PropertyEmployment & CompensationInternational Commercial & TradeTechnology, Media & Telecommunications Healthcare & Life Sciences RegulatoryConsumer HealthcareSupply ChainsWorkforce RedesignMergers & AcquisitionsCapital MarketsPrivate EquitySustainability and ESGProjectsRenewable Energy & Clean TechnologyDigital HealthAntitrust & CompetitionTaxLife Sciences Business Evolution SeriesWed, 20 Apr 2022 00:00:00 Z